Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

T14.SI
Current Price: 2.17 Price Change: +0.02 (+0.93%)

Price Chart

Market Cap Volume Previous Close Open Price
2.78B 32,100.00 2.15 2.15
Day Low Day High 52 Weeks High 52 Weeks Low
2.15 2.17 2.66 1.95
Dividend Rate Dividend Yield Beta Trailing P/E
0.18 8.24% 0.88 5.56
Forward P/E Average Volume Trailing EPS Forward EPS
8.35 142,881.00 N/A N/A

Industry: Drug Manufacturers - Specialty & Generic — Sector: Healthcare

Business Summary

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, together with its subsidiaries, produces and sells traditional Chinese medicine, western medicine, and other products primarily in the People's Republic of China. The company manufactures and sells of biochemical pharmaceutical products. It also engages in research and development of chinese patent medicines, chemical raw materials and preparations, and nutritional supplements. In addition, the company is involved in pharmaceutical and drug retail business. Further, it offers Suxiao Jiuxin pills, Qingyan drop pills, Jingwanhong ointment, Angong Niuhuang pills, Qingfei pills, anti-inflammatory pills, Qinggong Shoutao pills, Biqi capsules, Niuhuang Qingxin pills, Tongmai Yangxin pills, and Weichang An pills. Additionally, the company pharmaceutical logistic services. Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited was formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited and changed its name to Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited in May 2022. The company was founded in 1981 and is based in Tianjin, the People's Republic of China.

Data last updated: 2025-04-21 15:46:05 (Server time)